<DOC>
	<DOCNO>NCT01061437</DOCNO>
	<brief_summary>The purpose study compare effectiveness three different antibiotic regimen Helicobacter pylorus ( H. pylorus ) .</brief_summary>
	<brief_title>S0701 , Trial Three Antibiotic Regimens Eradicate Helicobacter Pylori ( H. Pylori )</brief_title>
	<detailed_description>Prevention gastric cancer eradication H. pylori one promising strategy reduce global impact cancer near term . Our long-term goal prevent gastric cancer develop validate effective , simple , low-cost approach eradication H. pylorus . Our immediate goal , therefore , conduct randomize study compare effectiveness three different drug regimen H. pylorus infection . The three study arm : Standard therapy - 14 day , 3-drug regimen Lansoprazole , amoxicillin clarithromycin ( PACx14 ) ; Concomitant therapy - 5 day , 4-drug regimen lansoprazole , amoxicillin , clarithromycin , metronidazole ( PACMx5 ) ; Sequential therapy - 10 day , 4-drug regimen lansoprazole , amoxicillin 5 day , follow lansoprazole , clarithromycin metronidazole 5 day ( PAx5/PCMx5 ) .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>positive Urea Breath Test document H. pylori infection age 21 65 year know allergy study drug member household participate study know medical condition ( H. pylorus ) would preclude require antibiotic therapy patient must willing discontinue alcohol use 15 day ( maximum duration treatment plus one day ) patient must willing discontinue use antacid duration study treatment patient must use proton pump inhibitor ( PPI ) within 30 day registration . Patients also must willing stop use nonstudy provide PPIs completion 6 week followup contact . patient must treat antibiotic H. pylorus past must take antibiotic within 30 day registration . patient must willing return 2 followup visit : 6 week randomization follow completion treatment &amp; 1 year randomization patient must willing allow submission blood assay serum marker bacterial virulence host genetic susceptibility environmental factor provide consent use specimen . current use antiretroviral therapy HIV AIDS diagnose congestive hear failure renal failure require dialysis diagnose hepatic failure result hyperbilirubinemia current prior malignancy except : adequately treat basal squamous cell skin cancer , situ cervical cancer , adequately treated Stage I Stage II cancer patient disease free 5 year pregnancy nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>H. pylorus</keyword>
</DOC>